Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.62
Delayed Data
As of Aug 26
 +0.02 / +0.26%
Today’s Change
5.40
Today|||52-Week Range
10.74
-10.88%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.60
Today’s open7.59
Day’s range7.52 - 7.65
Volume21,928
Average volume (3 months)120,615
Market cap$100.1M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-8.06%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc+0.02+1.28%
AKAOAchaogen Inc-0.06-1.59%
NVLSNivalis Therapeutics...+0.20+3.23%
MRTXMirati Therapeutics ...+0.11+2.21%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$7.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts

Partner Offers

Search for Jobs